-
Stocks in Asia traded mixed today. Nikkei added 0.2%, S&P/ASX 200 gained 0.1%, Kospi dropped 0.2% and indices from China traded over 1% lower
-
DAX futures point to a slightly higher opening of the European session
-
AstraZeneca rejects accusations that its coronavirus vaccine increases risk of blood clots. Meanwhile, the Netherlands became the latest country to suspend use of AstraZeneca vaccine
-
Total number of confirmed coronavirus cases surpassed 120 million
-
According to media reports, Japan plans not to extend state of emergency and end it on March 21st as planned, thanks to lower rate of hospitalization in the country
-
According to Reuters, India is to propose a law banning possession, issuing, mining and trading in cryptocurrencies
-
RBA Governor Lowe repeated that the Bank will maintain support for the economy until full employment and inflation target are reached
-
Chinese retail sales increased 33.8% YoY in February (exp. +32% YoY), industrial production increased 35.1% YoY (exp. 30% YoY) and urban investments jumped 35% YoY (exp. 40% YoY)
-
Japanese core machinery orders declined 4.5% MoM in January
-
Bitcoin dropped below $59,000 after breaking above $61,000 over the weekend
-
Oil is trading higher while natural gas declines. Precious metals and agricultural commodities drop
-
NZD and CAD are the best performing major currencies while AUD and JPY lag the most
NZDUSD has found support at the 0.7170 swing level and moved higher today. The pair tested 0.7200 mark but failed to break above it. Clearing this area would pave the way for another test of a key, near-term resistance at 0.7240. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
